[PDF][PDF] Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
…, Y Pride, M Hasan, GE Abraham, M Senitko… - Cell, 2021 - cell.com
SARS-CoV-2 infection can cause severe respiratory COVID-19. However, many individuals
present with isolated upper respiratory symptoms, suggesting potential to constrain viral …
present with isolated upper respiratory symptoms, suggesting potential to constrain viral …
Restoring pulmonary and sleep services as the COVID-19 pandemic lessens. From an association of pulmonary, critical care, and sleep division directors and …
…, SP Patil, M Rosenfeld, M Senitko… - Annals of the …, 2020 - atsjournals.org
Background: In March 2020, many elective medical services were canceled in response to
the coronavirus disease 2019 (COVID-19) pandemic. The daily case rate is now declining in …
the coronavirus disease 2019 (COVID-19) pandemic. The daily case rate is now declining in …
The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort
…, Y Pride, KJ Wilson, M Hasan, A Parker, M Senitko… - Gut …, 2021 - Taylor & Francis
To investigate the relationship between intestinal microbiota and SARS-CoV-2-mediated
pathogenicity in a United States, majority African American cohort. We prospectively collected …
pathogenicity in a United States, majority African American cohort. We prospectively collected …
[HTML][HTML] Bleeding risk with combination intrapleural fibrinolytic and enzyme therapy in pleural infection: an international, multicenter, retrospective cohort study
…, T Sanchez, P Sathyanarayan, R Semaan, M Senitko… - Chest, 2022 - Elsevier
Background Combination intrapleural fibrinolytic and enzyme therapy (IET) has been
established as a therapeutic option in pleural infection. Despite demonstrated efficacy, studies …
established as a therapeutic option in pleural infection. Despite demonstrated efficacy, studies …
Increased ACE2 levels and mortality risk of patients with COVID-19 on proton pump inhibitor therapy
…, K Ayyalasomayajula, A Parker, M Senitko… - Official journal of the …, 2021 - journals.lww.com
METHODS: We performed a prospective study of hospitalized coronavirus disease 2019 (COVID-19)
patients and COVID-negative controls to understand how PPI use may affect …
patients and COVID-negative controls to understand how PPI use may affect …
Feasibility of using the O-arm imaging system during ENB-rEBUS–guided peripheral lung biopsy: a dual-center experience
RJ Cho, M Senitko, J Wong, EH Dincer… - … of bronchology & …, 2021 - journals.lww.com
Background: There is a paucity of real-time imaging modalities available for the bronchoscopic
biopsy of peripheral lung nodules. We aim to demonstrate the feasibility of the O-arm …
biopsy of peripheral lung nodules. We aim to demonstrate the feasibility of the O-arm …
Microwave ablation for malignant central airway obstruction: a pilot study
M Senitko, CL Oberg, GE Abraham, WB Hillegass… - Respiration, 2022 - karger.com
Background: Malignant central airway obstruction (CAO) is a debilitating complication of
primary lung cancer and pulmonary metastases. Therapeutic bronchoscopy is used to palliate …
primary lung cancer and pulmonary metastases. Therapeutic bronchoscopy is used to palliate …
Safety and tolerability of vacuum versus manual drainage during thoracentesis: a randomized trial
M Senitko, AS Ray, TE Murphy… - … of bronchology & …, 2019 - journals.lww.com
Background: Pleural effusions may be aspirated manually or via vacuum during thoracentesis.
This study compares the safety, pain level, and time involved in these techniques. …
This study compares the safety, pain level, and time involved in these techniques. …
[HTML][HTML] Severe COVID-19 is associated with fungal colonization of the nasopharynx and potent induction of IL-17 responses in the nasal epithelium
…, RS Drake, Y Pride, GE Abraham III, M Senitko… - medRxiv, 2022 - ncbi.nlm.nih.gov
Recent case reports and epidemiological data suggest fungal infections represent an under-appreciated
complication among people with severe COVID-19. However, the frequency of …
complication among people with severe COVID-19. However, the frequency of …
[HTML][HTML] Examination of gene expression in saliva samples from COVID-19 patients to study the host defense response against SARS-CoV-2 in the oral cavity
…, EL Figgins, T Robinson, M Senitko… - Molecular oral …, 2021 - ncbi.nlm.nih.gov
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (COVID-19), which presents with respiratory symptoms including fever, …
coronavirus disease 2019 (COVID-19), which presents with respiratory symptoms including fever, …